Back to MORGAN STANLEY MORGAN STANLEY

ICCCICCC
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in IMMUCELL CORP

MORGAN STANLEY holds 233,910 shares of ICCC (IMMUCELL CORP), worth $2.4M as of 2026-Q2. The position was increased (+5.5% shares). ICCC represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$2.4M

Current Shares

233,910

Total Value Change

+$2.1M

Total Shares Change

+170,394

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
233,910
+5.5%
$2.4M0.0%$10.05
28
2026-Q1
Increased
221,716
+77.8%
$1.4M0.0%$6.40
39
2025-Q4
Increased
124,716
+18.6%
$767,0030.0%$6.11
20
2025-Q3
Increased
105,116
+0.2%
$656,9750.0%$6.18
17
2025-Q2
Increased
104,916
+36.4%
$730,2150.0%$6.75
22
2025-Q1
Increased
76,916
+21.9%
$368,4280.0%$5.01
19
2024-Q4
Decreased
63,116
-0.6%
$325,0470.0%$4.82
0
2024-Q3
Decreased
63,516
-4.9%
$230,5630.0%$3.55
0

Other major holders of ICCC: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used